Full-Time

Director R&D Clinical Outsourcing and Contracts

Remote

Confirmed live in the last 24 hours

Roivant Sciences

Roivant Sciences

201-500 employees

Develops biopharmaceuticals and RNA therapeutics

Biotechnology
Healthcare

Senior, Expert

Remote in USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • Minimum 7-10 years experience in Clinical Trial outsourcing and budgets
  • Experience in a small, fast-paced start up biotech is a plus
  • Experience with formats and process requirements to lead functional teams in CRO and vendor budget alignment
  • Experience in developing and negotiation of CRO/Sponsor budgets and Work Orders
  • Proven track record of guiding Sponsor through RFI, RFP, Bid Defense and Study Award for CROs and vendors
  • Ability to travel to CRO partners (as dictated by specific study needs), and New York main office, on an as-needed basis
  • Ability to deal with multiple priorities, multiple stakeholders, and aggressive timelines
  • Proven ability to independently manage multiple projects/tasks
  • Strong oral and written communication skills
Responsibilities
  • Independently lead and provide process, tools, and cross functional guidance in CRO and vendor selection process, from RFI to Study Award. Includes establishing baseline and alternative scenarios.
  • Review processes/practices of strategic business importance to identify inefficiencies and/or areas of opportunity for improvement; be comfortable in challenging existing practices and develop innovative solutions that aim at increasing operational efficiencies.
  • Initiate and lead discussions to facilitate the refinement of the process scope, goals, and deliverables and identify appropriate team actions and risks.
  • Manage resources and vendors that provide project support and ensure they are effectively onboarded, managed, and delivering on expected milestones.
  • Engage teams to help establish a continuous improvement culture and execute advanced problem-solving activities.
  • May oversee and mentor direct reports and/or contractors, providing leadership and training to support professional development and responsible for demonstration.
  • Assist Roivant R&D team as needed on asset diligence
  • Assist Roivant Central in building process and infrastructure to support Vant family

Roivant Sciences develops and delivers medicines and technologies aimed at improving patient health, focusing on drug candidates for genetic disorders and RNA therapeutics. The company operates by maximizing the potential of these candidates through a combination of in-house development and strategic partnerships, which helps build a strong pipeline of drugs. One of its key subsidiaries, Genevant, specializes in RNA therapeutics, utilizing proprietary delivery platforms for mRNA, RNAi, and gene editing to create effective treatments for specific diseases. Roivant generates revenue through drug development, licensing agreements, and partnerships, with the goal of bringing innovative treatments to market efficiently.

Company Stage

IPO

Total Funding

$1.8B

Headquarters

New York City, New York

Founded

2014

Growth & Insights
Headcount

6 month growth

0%

1 year growth

1%

2 year growth

-11%
Simplify Jobs

Simplify's Take

What believers are saying

  • Roivant's recent $7.1B deal with Roche to acquire Telavant highlights its strong potential for lucrative partnerships and significant financial growth.
  • The company's diverse pipeline, including promising RNA therapeutics and gene editing technologies, offers substantial opportunities for breakthrough treatments.
  • Strategic investments, such as the $2.02 million from Exchange Traded Concepts LLC, indicate strong investor confidence and financial stability.

What critics are saying

  • The failure of the lupus drug brepocitinib in Phase 2 trials underscores the inherent risks in drug development and potential setbacks.
  • Rumors of acquiring Immunovant, Inc. could lead to financial strain and integration challenges if not managed properly.

What makes Roivant Sciences unique

  • Roivant Sciences leverages a unique business model that combines in-house product development with strategic partnerships, setting it apart from traditional biopharmaceutical companies.
  • The company's focus on RNA therapeutics and genetic disorders, particularly through its subsidiary Genevant, positions it at the forefront of cutting-edge medical treatments.
  • Roivant's ability to rapidly advance its drug pipeline and form strategic alliances allows it to bring innovative treatments to market more quickly and efficiently than many competitors.

Help us improve and share your feedback! Did you find this helpful?